Erratum to Menthol Inhibits the Proliferation and Motility of Prostate Cancer DU145 Cells [Pathol. Oncol. Res., (2012), 18, (903-910), DOI 10.1007/s12253-012-9520-1];Menthol inhibits the proliferation and motility of prostate cancer DU145 cells

Pathology and Oncology Research

Volumn 18, Issue 4, 2012, Pages 903-910

  Wang, Yongzhi ^a   Wang, Xinghuan ^a   Yang, Zhonghua ^a   Zhu, Guangbin ^a   Chen, Dong ^a   Meng, Zhe ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Menthol; Migration; Proliferation; Prostate cancer; Transient receptor potential (TRP) channel

Indexed keywords

EID: 84868488271     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-015-0039-0     Document Type: Erratum

References (31)

1. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57(1):43-66
2. Chen Y, Clegg NJ, Scher HI (2009) Anti-androgens and androgendepleting therapies in prostate cancer: new agents for an established target. Lancet Oncol 10(10):981-991
3. Rosenthal SA, Sandler HM (2010) Treatment strategies for highrisk locally advanced prostate cancer. Nat Rev Urol 7(1):31-38
4. Taplin ME (2007) Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Nat Clin Pract Oncol 4(4):236-244
5. Damber JE, Aus G (2008) Prostate cancer. Lancet 371(9625):1710-1721
6. 2+ -ATPases 2B involvement in human prostate cancer cell growth control. J Biol Chem 276(50):47608-47614
7. 2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 66(4):2038-2047
8. 2+ homeostasis and apoptotic resistance of neuroendocrinedifferentiated prostate cancer cells. Cell Death Differ 11(3):321-330
9. 2+ current in human prostate cancer LNCaP cells: involvement in apoptosis. J Physiol 527(Pt 1):71-83
10. Vanden Abeele F, Skryma R, Shuba Y et al (2002) Bcl-2- dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1(2):169-179
11. 2+ transporter type 1. J Biol Chem 278(17):15381-15389
12. 2+ transport. Nat Rev Cancer 7(7):519-530
13. Tsavaler L, Shapero MH, Morkowski S, Laus R (2001) Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res 61(9):3760-3769
14. Henshall SM, Afar DE, Hiller J et al (2003) Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res 63 (14):4196-4203
15. Yang ZH, Wang XH, Wang HP, Hu LQ (2009) Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells. Asian J Androl 11(2):157-165
16. Patel T, Ishiuji Y, Yosipovitch G (2007) Menthol: a refreshing look at this ancient compound. J Am Acad Dermatol 57(5):873-878
17. McKemy DD, Neuhausser WM, Julius D (2002) Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416(6876):52-58
18. Peier AM, Moqrich A, Hergarden AC et al (2002) ATRP channel that senses cold stimuli and menthol. Cell 108(5):705-715
19. 2+ channel required for the survival of prostate cancer cells. Cancer Res 64(22):8365-8373
20. Valero M, Morenilla-Palao C, Belmonte C, Viana F (2010) Pharmacological and functional properties of TRPM8 channels in prostate tumor cells. Pflugers Arch-Eur J Physiol 461(1):99-114
21. Kim S, Nam J, Park E, Kim B, So I, Jeon J (2009) Menthol regulates TRPM8-independent processes in PC-3 prostate cancer cells. BBA-Mol Basis Dis 1792(1):33-38
22. Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS (2005) Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 434(7034):786-792
23. Story GM, Peier AM, Reeve AJ et al (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112(6):819-829
24. Bidaux G, Roudbaraki M, Merle C et al (2005) Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocr Relat Cancer 12(2):367-382
25. RIFM (Research Institute for Fragrance Materials, Inc.) (1975) Mutagenic evaluation of compound FDA 71-57, menthol. NTIS PB-245-444 (FDA 71-268). Unpublishee report from Food and Drug Administration, 14 January. Report Number 5713, RIFM, Woodcliff Lake, NJ, USA
26. Bernson VSM, Pettersson B (1983) The toxicity of menthol in short-term bioassays. Chem-Biol Interactions 46:233-246
27. Yamamura H, Ugawa S, Ueda T, Morita A, Shimada S (2008) TRPM8 activation suppresses cellular viability in human melanoma. Am J Physiol Cell Physiol 295:C296-C301
28. Lapenna S, Giordano A (2009) Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov 8(7):547-566
29. Pines J (1995) Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 308(Pt 3):697-711
30. Brooke GN, Bevan CL (2009) The role of androgen receptor mutations in prostate cancer progression. Curr Genomics 10 (1):18-25
31. Schlaepfer DD, Mitra SK, Ilic D (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692(2-3):77-102